Published in PLoS One on May 11, 2011
The advantages and limitations of trait analysis with GWAS: a review. Plant Methods (2013) 2.08
Detecting epistasis in human complex traits. Nat Rev Genet (2014) 1.61
A PheWAS approach in studying HLA-DRB1*1501. Genes Immun (2013) 1.42
eMERGEing progress in genomics-the first seven years. Front Genet (2014) 1.30
Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality. Genet Epidemiol (2011) 1.26
Gene-based testing of interactions in association studies of quantitative traits. PLoS Genet (2013) 1.23
Genomic analyses with biofilter 2.0: knowledge driven filtering, annotation, and model development. BioData Min (2013) 1.15
High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE. Clin Transl Sci (2012) 1.13
Secondary use of clinical data: the Vanderbilt approach. J Biomed Inform (2014) 1.12
Design patterns for the development of electronic health record-driven phenotype extraction algorithms. J Biomed Inform (2014) 1.06
Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc (2015) 1.04
Phenome-wide association studies (PheWASs) for functional variants. Eur J Hum Genet (2014) 0.99
Generalization of variants identified by genome-wide association studies for electrocardiographic traits in African Americans. Ann Hum Genet (2013) 0.99
Analysis pipeline for the epistasis search - statistical versus biological filtering. Front Genet (2014) 0.96
ATHENA: a tool for meta-dimensional analysis applied to genotypes and gene expression data to predict HDL cholesterol levels. Pac Symp Biocomput (2013) 0.95
Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat Rev Genet (2016) 0.92
Application of clinical text data for phenome-wide association studies (PheWASs). Bioinformatics (2015) 0.87
Admixture mapping and subsequent fine-mapping suggests a biologically relevant and novel association on chromosome 11 for type 2 diabetes in African Americans. PLoS One (2014) 0.86
Hypothesis-based analysis of gene-gene interactions and risk of myocardial infarction. PLoS One (2012) 0.86
The electronic health record for translational research. J Cardiovasc Transl Res (2014) 0.86
Biology-Driven Gene-Gene Interaction Analysis of Age-Related Cataract in the eMERGE Network. Genet Epidemiol (2015) 0.83
Pathway-guided identification of gene-gene interactions. Ann Hum Genet (2014) 0.83
CardioGxE, a catalog of gene-environment interactions for cardiometabolic traits. BioData Min (2014) 0.83
Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci. Mol Vis (2014) 0.82
Gene-gene combination effect and interactions among ABCA1, APOA1, SR-B1, and CETP polymorphisms for serum high-density lipoprotein-cholesterol in the Japanese population. PLoS One (2013) 0.82
The challenges of genome-wide interaction studies: lessons to learn from the analysis of HDL blood levels. PLoS One (2014) 0.80
Analysis of multiple association studies provides evidence of an expression QTL hub in gene-gene interaction network affecting HDL cholesterol levels. PLoS One (2014) 0.79
CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake. PLoS One (2012) 0.78
Properties of local interactions and their potential value in complementing genome-wide association studies. PLoS One (2013) 0.78
The expression of embryonic liver development genes in hepatitis C induced cirrhosis and hepatocellular carcinoma. Cancers (Basel) (2012) 0.77
Ethical and practical challenges to studying patients who opt out of large-scale biorepository research. J Am Med Inform Assoc (2013) 0.77
A common functional promoter variant links CNR1 gene expression to HDL cholesterol level. Nat Commun (2013) 0.77
The effects of electronic medical record phenotyping details on genetic association studies: HDL-C as a case study. BioData Min (2015) 0.76
Identifying gene-gene interactions that are highly associated with Body Mass Index using Quantitative Multifactor Dimensionality Reduction (QMDR). BioData Min (2015) 0.76
How Gene Networks Can Uncover Novel CVD Players. Curr Cardiovasc Risk Rep (2014) 0.75
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG). Pac Symp Biocomput (2016) 0.75
Identifying gene-gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts. Hum Genet (2016) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Finding the missing heritability of complex diseases. Nature (2009) 67.95
The Pfam protein families database. Nucleic Acids Res (2004) 56.46
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
The Pfam protein families database. Nucleic Acids Res (2007) 30.53
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Common genetic variation and human traits. N Engl J Med (2009) 21.03
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Personal genomes: The case of the missing heritability. Nature (2008) 19.56
GenABEL: an R library for genome-wide association analysis. Bioinformatics (2007) 18.10
The NCBI dbGaP database of genotypes and phenotypes. Nat Genet (2007) 17.93
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53
The genetic landscape of a cell. Science (2010) 16.52
DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res (2002) 15.70
Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet (2010) 14.81
Reactome: a knowledge base of biologic pathways and processes. Genome Biol (2007) 13.36
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32
Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet (2009) 12.07
Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet (2008) 12.07
Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther (2008) 11.67
Genomewide association studies and assessment of the risk of disease. N Engl J Med (2010) 11.51
Genetic heterogeneity in human disease. Cell (2010) 10.67
High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet (2008) 9.68
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet (2002) 9.18
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet (2008) 7.33
Genomewide rapid association using mixed model and regression: a fast and simple method for genomewide pedigree-based quantitative trait loci association analysis. Genetics (2007) 7.09
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics (2010) 7.07
Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet (2010) 6.44
LDL-cholesterol concentrations: a genome-wide association study. Lancet (2008) 6.44
Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA (2003) 6.17
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet (2008) 6.06
MedEx: a medication information extraction system for clinical narratives. J Am Med Inform Assoc (2010) 6.01
Screening large-scale association study data: exploiting interactions using random forests. BMC Genet (2004) 5.76
A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet (2007) 5.64
Bioinformatics challenges for genome-wide association studies. Bioinformatics (2010) 4.45
Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA (2005) 4.22
Clinical practice. Low HDL cholesterol levels. N Engl J Med (2005) 3.81
Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc Natl Acad Sci U S A (2008) 3.56
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature (1991) 3.48
Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation (2010) 3.35
Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet (2004) 3.35
Automated acquisition of disease drug knowledge from biomedical and clinical documents: an initial study. J Am Med Inform Assoc (2007) 3.09
Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem (2004) 2.91
Increasing the power of identifying gene x gene interactions in genome-wide association studies. Genet Epidemiol (2008) 2.84
Quality control procedures for genome-wide association studies. Curr Protoc Hum Genet (2011) 2.48
Two-locus models of disease. Genet Epidemiol (1992) 2.40
Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac Symp Biocomput (2009) 2.26
Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks. Nat Genet (2010) 2.16
Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet (2008) 1.89
Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. Bioessays (2009) 1.82
Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions. Circ Cardiovasc Genet (2008) 1.82
Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank. Basic Clin Pharmacol Toxicol (2007) 1.64
A plasma-membrane E-MAP reveals links of the eisosome with sphingolipid metabolism and endosomal trafficking. Nat Struct Mol Biol (2010) 1.44
Quantification of the clinical modifiers impacting high-density lipoprotein cholesterol in the community: Personalized Medicine Research Project. Prev Cardiol (2010) 1.14
Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository. Basic Clin Pharmacol Toxicol (2008) 1.09
The metabolic syndrome: concepts and controversy. Mayo Clin Proc (2006) 1.06
High density lipoprotein-induced signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation of Ras. J Biol Chem (2003) 1.03
Replication in genetic studies of complex traits. Ann Hum Genet (2004) 0.99
Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent. Pharmacogenomics (2009) 0.86
Genome-wide approaches to finding novel genes for lipid traits: the start of a long road. Circ Cardiovasc Genet (2008) 0.84
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics (2003) 9.91
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics (2010) 7.07
Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet (2010) 6.44
MedEx: a medication information extraction system for clinical narratives. J Am Med Inform Assoc (2010) 6.01
Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med (2011) 5.82
Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
CYP4F2 genetic variant alters required warfarin dose. Blood (2008) 4.23
Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc (2011) 4.20
Concern Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation (2002) 4.16
A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol (2007) 4.15
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest (2006) 4.06
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet (2011) 3.94
Pattern of sequence variation across 213 environmental response genes. Genome Res (2004) 3.93
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85
New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85
Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci (2010) 3.84
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med (2009) 3.35
Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation (2010) 3.35
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21
Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation (2004) 3.02
Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc (2013) 3.00
The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol (2011) 2.98
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation (2002) 2.98
Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc (2012) 2.94
Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data. PLoS One (2013) 2.81
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation (2005) 2.78
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation (2008) 2.72
Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation (2006) 2.72
A study of machine-learning-based approaches to extract clinical entities and their assertions from discharge summaries. J Am Med Inform Assoc (2011) 2.70
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics (2006) 2.66
Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm (2007) 2.62
Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Circ Res (2012) 2.61
Visualizing SNP statistics in the context of linkage disequilibrium using LD-Plus. Bioinformatics (2010) 2.59
Data from clinical notes: a perspective on the tension between structure and flexible documentation. J Am Med Inform Assoc (2011) 2.57
Machine learning for detecting gene-gene interactions: a review. Appl Bioinformatics (2006) 2.56
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
Drug-induced long QT syndrome. Pharmacol Rev (2010) 2.55
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
Data simulation software for whole-genome association and other studies in human genetics. Pac Symp Biocomput (2006) 2.49
Clinical genetics provider real-time workflow study. Genet Med (2008) 2.49
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res (2007) 2.48
Quality control procedures for genome-wide association studies. Curr Protoc Hum Genet (2011) 2.48
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature (2013) 2.46